Gilead’s HIV prevention treatment found 100% effective in late-stage trial
Gilead’s HIV prevention treatment found 100% effective in late-stage trial
Gilead Sciences Inc.’s stock jumped early Thursday after the company said its experimental injection for HIV prevention was found 100% effective in a late-stage trial.
